Veru Inc Cash Flow Conversion Efficiency
Veru Inc cash flow conversion efficiency. Based on the latest financial reports, Veru Inc (VERU) has a cash flow conversion efficiency ratio of -0.166x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.17 Million) by net assets ($37.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Veru Inc (1990–2025)
Cash flow conversion efficiency of Veru Inc from 1990 to 2025. This chart illustrates how Veru Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Veru Inc stock price for real-time trading data and today's change.
Veru Inc Cash Flow Conversion Ratio Explained
Veru Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Veru Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Veru Inc ranked by their cash flow conversion efficiency. Also see Veru Inc (VERU) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Co2 Capsol AS
OL:CAPSL
|
-0.288x |
|
Mr Bricolage
PA:ALMRB
|
-0.020x |
|
Vardhman Acrylics Limited
NSE:VARDHACRLC
|
-0.045x |
|
GeneFerm Biotechnology Co Ltd
TWO:1796
|
0.002x |
|
Liberty Shoes Limited
NSE:LIBERTSHOE
|
0.117x |
|
Neofect Co.Ltd
KQ:290660
|
-0.036x |
|
Reino Capital SA
WAR:RNC
|
0.064x |
|
JASTECH Ltd
KQ:090470
|
-0.307x |
Annual Cash Flow Conversion Efficiency for Veru Inc (1990–2025)
The table below shows the annual cash flow conversion efficiency of Veru Inc from 1990 to 2025. Review Veru Inc (VERU) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $18.33 Million | $-30.04 Million | -1.639x | -144.25% |
| 2024-09-30 | $32.32 Million | $-21.68 Million | -0.671x | +85.00% |
| 2023-09-30 | $19.68 Million | $-88.01 Million | -4.473x | -679.55% |
| 2022-09-30 | $82.80 Million | $-47.51 Million | -0.574x | -461.16% |
| 2021-09-30 | $152.29 Million | $-15.57 Million | -0.102x | -59.51% |
| 2020-09-30 | $30.11 Million | $-1.93 Million | -0.064x | +62.22% |
| 2019-09-30 | $32.33 Million | $-5.49 Million | -0.170x | +56.68% |
| 2018-09-30 | $29.48 Million | $-11.55 Million | -0.392x | -2030.67% |
| 2017-09-30 | $48.45 Million | $982.89K | 0.020x | +140.15% |
| 2016-09-30 | $33.93 Million | $-1.71 Million | -0.051x | -8.09% |
| 2015-09-30 | $33.13 Million | $-1.55 Million | -0.047x | -135.79% |
| 2014-09-30 | $28.07 Million | $3.67 Million | 0.131x | -65.22% |
| 2013-09-30 | $31.40 Million | $11.79 Million | 0.376x | -12.18% |
| 2012-09-30 | $24.22 Million | $10.36 Million | 0.428x | +2.81% |
| 2011-09-30 | $16.75 Million | $6.97 Million | 0.416x | +68.09% |
| 2010-09-30 | $16.13 Million | $3.99 Million | 0.247x | -44.22% |
| 2009-09-30 | $12.95 Million | $5.75 Million | 0.444x | +1.48% |
| 2008-09-30 | $9.71 Million | $4.24 Million | 0.437x | +7842.94% |
| 2007-09-30 | $7.45 Million | $-42.05K | -0.006x | -110.06% |
| 2006-09-30 | $4.77 Million | $267.94K | 0.056x | +193.26% |
| 2005-09-30 | $3.31 Million | $-199.26K | -0.060x | +49.30% |
| 2004-09-30 | $1.83 Million | $-216.76K | -0.119x | -120.19% |
| 2003-09-30 | $493.13K | $290.01K | 0.588x | +197.89% |
| 2002-09-30 | $630.28K | $-378.65K | -0.601x | +94.97% |
| 2001-09-30 | $52.32K | $-625.02K | -11.945x | -902.35% |
| 2000-09-30 | $-693.07K | $-1.03 Million | 1.489x | +190.28% |
| 1999-09-30 | $1.72 Million | $-2.84 Million | -1.649x | -75.79% |
| 1998-09-30 | $2.93 Million | $-2.75 Million | -0.938x | +40.55% |
| 1997-09-30 | $3.55 Million | $-5.61 Million | -1.578x | -192.58% |
| 1996-09-30 | $7.55 Million | $-4.07 Million | -0.539x | +10.89% |
| 1995-09-30 | $7.60 Million | $-4.60 Million | -0.605x | +0.17% |
| 1994-09-30 | $12.70 Million | $-7.70 Million | -0.606x | -1403.54% |
| 1993-09-30 | $4.30 Million | $200.00K | 0.047x | +112.79% |
| 1992-09-30 | $5.50 Million | $-2.00 Million | -0.364x | -55.37% |
| 1991-09-30 | $4.70 Million | $-1.10 Million | -0.234x | -583.69% |
| 1990-09-30 | $6.20 Million | $300.00K | 0.048x | -- |
About Veru Inc
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosa… Read more